Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $1.80
Actual EPS: $1.60
Company overview
Market Cap$9.2B
SectorHealth Technology
IndustryBiotechnology